Singapore markets closed

BioInvent International AB (publ) (BINV.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
36.95+3.40 (+10.13%)
At close: 05:29PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-334,518
-330,304
-42,503
-278,444
-76,333
-
Depreciation & amortisation
17,603
16,755
14,724
14,610
12,004
-
Stock-based compensation
3,310
2,950
1,789
1,138
-41
-
Change in working capital
6,717
-10,145
-6,775
17,028
1,196
-
Inventory
-
-338
5,342
-12,769
1,301
-
Other working capital
-341,131
-354,995
-53,604
-259,103
-69,322
-
Other non-cash items
-
-
1,789
1,138
-41
379
Net cash provided by operating activities
-328,668
-341,691
-41,227
-245,843
-62,622
-
Cash flows from investing activities
Investments in property, plant and equipment
-12,463
-13,304
-12,377
-13,260
-6,700
-
Purchases of investments
-
-
-616,471
-454,282
0
-
Sales/maturities of investments
-
72,985
-
-
-
-
Net cash used for investing activities
254,737
59,681
-628,848
-467,542
-6,700
-
Net change in cash
-81,902
-258,871
-396,588
181,485
575,295
-
Cash at beginning of period
542,516
515,047
910,755
729,270
153,975
-
Cash at end of period
460,614
259,548
515,047
910,755
729,270
-
Free cash flow
Operating cash flow
-328,668
-341,691
-41,227
-245,843
-62,622
-
Capital expenditure
-12,463
-13,304
-12,377
-13,260
-6,700
-
Free cash flow
-341,131
-354,995
-53,604
-259,103
-69,322
-